Oric Pharmaceuticals (ORIC) Other Operating Expenses (2020 - 2022)

Oric Pharmaceuticals (ORIC) posted Other Operating Expenses of $5.0 million for Q3 2022, down 57.88% on a QoQ basis from $11.9 million in Q4 2020.

Oric Pharmaceuticals (ORIC) Other Operating Expenses (2020 - 2022) Analysis & Trends

Oric Pharmaceuticals' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $5.0 million for Q3 2022.

Quarterly Other Operating Expenses changed N/A year-over-year to $5.0 million in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $5.0 million (changed N/A YoY) and the FY2022 annual result came in at $5.0 million, changed N/A from the prior year.
Other Operating Expenses was $5.0 million for Q3 2022 at Oric Pharmaceuticals, down from $11.9 million in the prior quarter.
Across five years, Other Operating Expenses topped out at $13.0 million in Q3 2020 and bottomed at $5.0 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Oric Pharmaceuticals	1.29 Bn	1.01 Bn	-

Download Data